1,25‐dihydroxy‐vitamin‐D3 enhances antiproliferative effect and transcription of TGF‐β1 on human keratinocytes in culture

Journal of Cellular Physiology

Volumn 151, Issue 3, 1992, Pages 579-587

  Kim, Hee‐Jong ^a   Abdelkader, Neamatallah ^a   Katz, Marion ^a   McLane, John A ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

24,25 DIHYDROXYVITAMIN D; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL;

ANTIBODIES; CALCITRIOL; CELL DIVISION; CELLS, CULTURED; DRUG SYNERGISM; GENE EXPRESSION; HUMAN; KERATINOCYTES; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 0026763783     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.1041510318     Document Type: Article

References (73)

1. Fibronectin inhibits the terminal differentiation of human keratinocytes
2. Localized production of TGF‐(beta) mRNA in tumour promoter‐stimulated mouse epidermis
3. Complex regulation of transforming growth factor‐beta‐1, factor‐beta‐2, and factor‐beta‐3 messenger RNA expression in mouse fibroblasts and keratinocytes by transforming growth factor‐beta‐1 and factor‐beta‐2
4. Retinoic acid induces secretion of transforming growth factor‐beta in cultured human keratinocytes
5. Immunocytochemical detection of 1,25‐dihydroxyvitamin D receptors in normal human tissues
6. Free, not total, 1,25‐dihyroxyvitamin D regulates 25‐hydroxyvitamin D metabolism by keratinocytes
7. Assessment of the free fraction of 25‐hydroxyvitamin D in serum and its regulation by albumin and the vitamin D binding protein
8. 3 production by human keratinocytes. Kinetics and regulation
9. 3
10. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum‐free media
11. Physiochemical activation of recombinant latent transforming growth factor‐beta's 1, 2, and 3
12. Site‐directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor
13. Effects of bone associated growth factors on DNA, collagen, and osteocalcin synthesis in cultured fetal rat calvariae
14. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction
15. 3, J
16. 3 receptor in target cells
17. Growth modulation of mouse keratinocytes by transforming growth factors
18. Transforming growth factor‐beta in psoriasis: Pathogenesis and therapy
19. Transforming growth factor beta mRNA is expressed in normal and psoriatic epidermis and has similar biological effects on normal and psoriatic lesional cultured keratinocytes
20. 3 on binding and internalization of epidermal growth factor in cultured cells. Studies on BT‐20 cells using quantitative electron microscope autoradiography
21. The pro‐domain of pre‐pro‐trans‐forming growth factor‐beta‐ 1 when independently expressed is a functional binding protein for the mature growth factor
22. Retinoic acid induces transforming growth factor‐β2 in cultured keratinocytes and mouse epidermis
23. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
24. Transcription and expression of transforming growth factor type‐beta in the skin of progressive systemic sclerosis—A mediator of fibrosis
25. Specific uptake of retinoids into human promyelocytic leukemia cells HL‐60 by retinoid‐specific binding protein: Possibly the true retinoid receptor
26. 3 receptor concentration in mouse skin and intestine
27. 3
28. Acidic cellular environments: Activation of latent TGF‐β and sensitization of cellular responses to TGF‐β and EGF
29. Transforming growth factor‐beta 1 localization in normal and psoriatic epidermal keratinocytes in situ
30. 3 analogue (MC 903) in a double blind study
31. Inhibition of connective tissue formation in dermal wounds covered with synthetic, moisture vapor permeable dressings and its reversal by transforming growth factor‐beta
32. 3, in the differentiation and development of skin
33. Proteolytic activation of latent transforming growth factor‐β from fibroblast‐conditioned medium
34. 3 is calcium dependent and coincides with an increase in phosphotidylinositol metabolism
35. Changes in keratinocyte maturation during wound healing
36. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor‐β
37. 3 on normal human keratinocytes cultured in serum‐free medium
38. 3 on human keratinocytes grown under different culture conditions
39. Role for carbohydrate structures in TGF‐β1 latency
40. 3 on leukemic cells
41. 3. A review of our experiences
42. 3 treatment in psoriasis vulgaris
43. Transforming growth factor (beta) modulates epidermal growth factor‐induced phosphoinositide metabolism and intracellular calcium levels
44. Secretion and binding of transforming growth factor‐beta by scleroderma and normal dermal fibroblasts
45. 125I‐epidermal growth factor binding to cultured keratinocyte by antiproliferative molecules: Gamma interferon, cyclosporin A, and transforming growth factor‐beta
46. Inhibition of normal rat kidney cell growth by transforming growth factor‐β is mediated by collagen
47. Activation of bone‐derived latent TGF‐β complex by isolated osteoclasts
48. Production of TGF‐alpha and TGF‐beta by cultured keratinocytes, skin and oral squamous cell carcinomas. Potential autocrine regulation of normal and malignant epithelial cell proliferation
49. Transforming growth factor‐beta inhibits bone resorption in fetal rat long bone cultures
50. Transforming growth factor‐beta‐1 suppression of c‐myc gene transcription. Role in inhibition of keratinocyte proliferation
51. TGF‐β‐1 inhibition of c‐myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with prb binding domains
52. 1,25‐dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation
53. Vitamin D and epidermal differentiation: Evidence for a role of endogenously produced vitamin D metabolites in keratinocyte differentiation
54. Keratinocyte commitment to differentiation. Regulation by growth factors and calcium
55. 3 provokes a dramatic acceleration of epidermal differentiation
56. Onset of epidermal differentiation in rapidly proliferating basal keratinocytes
57. Regulation of growth and differentiation of human keratinocytes by type (beta) transforming growth factor and epidermal growth factor
58. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
59. Peptide growth factors and their receptors
60. Type beta transforming growth factor: A bifunctional regulator of cellular growth
61. Cellular mechanisms of TGF‐beta action
62. Biphasic effects of transforming growth factor‐beta on the production of osteoclast‐like cells in mouse bone marrow cultures; the role of prostaglandins in the generations of these cells
63. Growth of normal human keratinocytes and fibroblasts in serum‐free medium is stimulated by acidic and basic fibroblast growth factor
64. 3 on the morphologic and biochemical differentiation of cultured human keratinocytes grown in serum‐free conditions
65. A novel approach for the evaluation and treatment of psoriasis
66. The multifunctional nature of peptide growth factors
67. Some recent advances in the chemistry and biology of transforming growth factor‐beta
68. Vitamin D: Soltriol, the heliogenic steroid hormone: Somatotrophic activator and modulator
69. 3 in skin
70. 3 on the metabolism of polyphosphoinositides in murine epidermal keratinocytes
71. Trans retinoic acid enhances the growth response of epidermal keratinocytes to epidermal growth factor and transforming growth factor‐beta
72. Transforming growth factor‐(beta) stimulates the expression fo fibronectin by human keratinocytes
73. 3. Role of protein kinase‐C translocation